Modification of a loop sequence between α-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA α-helices 4 and 5 loop improves replication in cynomolgus monkey cells

Retrovirology

Volumn 6, Issue , 2009, Pages

  Kuroishi, Ayumu ^a   Saito, Akatsuki ^b   Shingai, Yasuhiro ^a   Shioda, Tatsuo ^a   Nomaguchi, Masako ^c   Adachi, Akio ^c   Akari, Hirofumi ^b   Nakayama, Emi E ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; TRIPARTITE MOTIF PROTEIN 5; VIF PROTEIN; VIRUS PROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE DEPLETION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN MODIFICATION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; WILD TYPE; ANIMAL; CELL CULTURE; GENETIC RECOMBINATION; GENETICS; HUMAN; MACACA; MONONUCLEAR CELL; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA FASCICULARIS; MACACA MULATTA; MIRIDAE; PAN; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CAPSID PROTEINS; CELL LINE; CELLS, CULTURED; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA FASCICULARIS; RECOMBINATION, GENETIC; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 69349095390     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-70     Document Type: Article

References (48)

1. Shibata R Sakai H Kawamura M Tokunaga K Adachi A Early replication block of human immunodeficiency virus type 1 in monkey cells J Gen Virol 1995, 76(Pt 11):2723-2730. 10.1099/0022-1317-76-11-2723 7595379
2. Himathongkham S Luciw PA Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells Virology 1996, 219:485-488. 10.1006/viro.1996.0276 8638416
3. Hofmann W Schubert D LaBonte J Munson L Gibson S Scammell J Ferrigno P Sodroski J Species-specific, postentry barriers to primate immunodeficiency virus infection J Virol 1999, 73:10020-10028. 113053 10559316
4. Shibata R Kawamura M Sakai H Hayami M Ishimoto A Adachi A Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells J Virol 1991, 65:3514-3520. 241342 2041078
5. Mascola JR Stiegler G VanCott TC Katinger H Carpenter CB Hanson CE Beary H Hayes D Frankel SS Birx DL Lewis MG Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies Nat Med 2000, 6:207-210. 10.1038/ 72318 10655111
6. Nishimura Y Igarashi T Haigwood N Sadjadpour R Plishka RJ Buckler-White A Shibata R Martin MA Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies J Virol 2002, 76:2123-2130. 10.1128/jvi.76.5.2123-2130.2002 153825 11836389
7. Shibata R Igarashi T Haigwood N Buckler-White A Ogert R Ross W Willey R Cho MW Martin MA Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys Nat Med 1999, 5:204-210. 10.1038/5568 9930869
8. Matano T Shibata R Siemon C Connors M Lane HC Martin MA Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques J Virol 1998, 72:164-169. 109361 9420212
9. Migueles SA Sabbaghian MS Shupert WL Bettinotti MP Marincola FM Martino L Hallahan CW Selig SM Schwartz D Sullivan J Connors M HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors Proc Natl Acad Sci USA 2000, 97:2709-2714. 10.1073/pnas.050567397 15994 10694578
10. Nixon DF Townsend AR Elvin JG Rizza CR Gallwey J McMichael AJ HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides Nature 1988, 336:484-487. 10.1038/336484a0 2461519
11. Harris RS Bishop KN Sheehy AM Craig HM Petersen-Mahrt SK Watt IN Neuberger MS Malim MH DNA deamination mediates innate immunity to retroviral infection Cell 2003, 113:803-809. 10.1016/ S0092-8674(03)00423-9 12809610
12. Mangeat B Turelli P Caron G Friedli M Perrin L Trono D Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 2003, 424:99-103. 10.1038/nature01709 12808466
13. Sheehy AM Gaddis NC Choi JD Malim MH Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 2002, 418:646-650. 10.1038/nature00939 12167863
14. Mariani R Chen D Schrofelbauer B Navarro F Konig R Bollman B Munk C Nymark-McMahon H Landau NR Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 2003, 114:21-31. 10.1016/S0092-8674(03)00515-4 12859895
15. Marin M Rose KM Kozak SL Kabat D HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat Med 2003, 9:1398-1403. 10.1038/nm946 14528301
16. Sheehy AM Gaddis NC Malim MH The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat Med 2003, 9:1404-1407. 10.1038/nm945 14528300
17. Goila-Gaur R Strebel K HIV-1 Vif, APOBEC, and intrinsic immunity Retrovirology 2008, 5:51. 10.1186/1742-4690-5-51 2443170 18577210
18. Berthoux L Sebastian S Sokolskaja E Luban J Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA J Virol 2004, 78:11739-11750. 10.1128/JVI.78.21.11739-11750.2004 523245 15479815
19. Kootstra NA Munk C Tonnu N Landau NR Verma IM Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells Proc Natl Acad Sci USA 2003, 100:1298-1303. 10.1073/ pnas.0337541100 298767 12547912 2003
20. Nakayama EE Shingai Y Kono K Shioda T TRIM5alpha-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells Virology 2008, 375:514-520. 10.1016/ j.virol.2008.02.028 18367226
21. Kamada K Igarashi T Martin MA Khamsri B Hatcho K Yamashita T Fujita M Uchiyama T Adachi A Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells Proc Natl Acad Sci USA 2006, 103:16959-16964. 10.1073/pnas.0608289103 1622925,1622925 17065315
22. Igarashi T Iyengar R Byrum RA Buckler-White A Dewar RL Buckler CE Lane HC Kamada K Adachi A Martin MA Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques J Virol 2007, 81:11549-11552. 10.1128/JVI.00960-07 2045513 17670817
23. Hatziioannou T Princiotta M Piatak M Jr Yuan F Zhang F Lifson JD Bieniasz PD Generation of simian-tropic HIV-1 by restriction factor evasion Science 2006, 314:95. 10.1126/science.1130994 17023652
24. Stremlau M Owens CM Perron MJ Kiessling M Autissier P Sodroski J The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys Nature 2004, 427:848-853. 10.1038/nature02343 14985764
25. Luban J Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection J Virol 2007, 81:1054-1061. 10.1128/JVI.01519-06 1797489 16956947
26. Towers GJ The control of viral infection by tripartite motif proteins and cyclophilin A Retrovirology 2007, 4:40. 10.1186/1742-4690-4-40 1906832 17565686
27. Li Y Li X Stremlau M Lee M Sodroski J Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection J Virol 2006, 80:6738-6744. 10.1128/JVI.00270-06 1489046 16809279
28. Nakayama EE Miyoshi H Nagai Y Shioda T A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection J Virol 2005, 79:8870-8877. 10.1128/JVI.79.14.8870-8877.2005 1168783 15994780
29. Ohkura S Yap MW Sheldon T Stoye JP All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction J Virol 2006, 80:8554-8565. 10.1128/JVI.00688-06 1563890 16912305
30. Ozato K Shin DM Chang TH Morse HC 3rd TRIM family proteins and their emerging roles in innate immunity Nat Rev Immunol 2008, 8:849-860. 10.1038/nri2413 18836477
31. Ylinen LM Keckesova Z Wilson SJ Ranasinghe S Towers GJ Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles J Virol 2005, 79:11580-11587. 10.1128/JVI.79.18.11580-11587.2005 1212619 16140735
32. Song H Nakayama EE Yokoyama M Sato H Levy JA Shioda T A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas J Virol 2007, 81:7280-7285. 10.1128/JVI.00406-07 1933286 17475650
33. Adachi A Gendelman HE Koeing S Folks T Willey R Rabson A Martin MA Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J Virol 1986, 59:284-291. 253077 3016298
34. Kono K Song H Shingai Y Shioda T Nakayama EE Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection Virology 2008, 373:447-456. 10.1016/j.virol.2007.12.022 18201746
35. Akari H Mori K Terao K Otani I Fukasawa M Mukai R Yoshikawa Y In vitro immortalization of Old World monkey T lymphocytes with Herpesvirus saimiri: Its susceptibility to infection with simian immunodeficiency viruses Virology 1996, 218:382-388. 10.1006/viro.1996.0207 8610465
36. Miyoshi H Takahashi M Gage FH Verma IM Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector Proc Natl Acad Sci USA 1997, 94:10319-10323. 10.1073/pnas.94.19.10319 23360 9294208
37. Miyoshi H Blomer U Takahashi M Gage FH Verma IM Development of a self-inactivating lentivirus vector J Virol 1998, 72:8150-8157. 110156 9733856
38. Akari H Fukumori T Iida S Adachi A Induction of apoptosis in Herpesvirus saimiri-immortalized T lymphocytes by blocking interaction of CD28 with CD80/CD86 Biochem Biophys Res Commun 1999, 263:352-356. 10.1006/ bbrc.1999.1364 10491296
39. Lin TY Emerman M Cyclophilin A interacts with diverse lentiviral capsids Retrovirology 2006, 3:70. 10.1186/1742-4690-3-70 1622752 17038183
40. Besnier C Takeuchi Y Towers G Restriction of lentivirus in monkeys Proc Natl Acad Sci USA 2002, 99:11920-11925. 10.1073/pnas.172384599 129369 12154231
41. Cowan S Hatziioannou T Cunningham T Muesing MA Gottlinger HG Bieniasz PD Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism Proc Natl Acad Sci USA 2002, 99:11914-11919. 10.1073/pnas.162299499 129368 12154227
42. Hatziioannou T Cowan S Goff SP Bieniasz PD Towers GJ Restriction of multiple divergent retroviruses by Lv1 and Ref1 Embo J 2003, 22:385-394. 10.1093/emboj/cdg042 140727 12554640
43. Maegawa H Nakayama EE Kuroishi A Shioda T Silencing of tripartite motif protein (TRIM) 5alpha mediated anti-HIV-1 activity by truncated mutant of TRIM5alpha J Virol Methods 2008, 151:249-256. 10.1016/ j.jviromet.2008.04.012 18524394
44. Lin TY Emerman M Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1 Virology 2008, 379:335-341. 10.1016/ j.virol.2008.06.037 18678385
45. Hatziioannou T Ambrose Z Chung NP Piatak M Jr Yuan F Trubey CM Coalter V Kiser R Schneider D Smedley J Pung R Gathuka M Estes JD Veazey RS KewalRamani VN Lifson JD Bieniasz PD A macaque model of HIV-1 infection Proc Natl Acad Sci USA 2009, 106:4425-4429. 10.1073/pnas.0812587106 19255423
46. Kuang YQ Tang X Liu FL Jiang XL Zhang YP Gao G Zheng YT Genotyping of TRIM5 locus in northern pig-tailed macaques (Macaca leonina), a primate species susceptible to Human Immunodeficiency Virus type 1 infection Retrovirology 2009, 6:58. 10.1186/1742-4690-6-58 2703620 19505341
47. Virgen CA Kratovac Z Bieniasz PD Hatziioannou T Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species Proc Natl Acad Sci USA 2008, 105:3563-3568. 10.1073/pnas.0709258105 2265128 18287034
48. Brennan G Kozyrev Y Kodama T Hu SL Novel TRIM5 isoforms expressed by Macaca nemestrina J Virol 2007, 81:12210-12217. 10.1128/JVI.02499-06 2168977 17804491